IFF
IFF
International Flavors & Fragrances Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $2.74B ▲ | $739M ▼ | $169M ▲ | 6.17% ▲ | $0.66 ▲ | $499M ▲ |
| Q4-2025 | $2.59B ▼ | $777M ▲ | $31M ▼ | 1.2% ▼ | $0.07 ▼ | $308M ▼ |
| Q3-2025 | $2.69B ▼ | $757M ▼ | $40M ▼ | 1.48% ▼ | $0.16 ▼ | $351M ▼ |
| Q2-2025 | $2.76B ▼ | $832M ▼ | $612M ▲ | 22.14% ▲ | $2.39 ▲ | $837M ▲ |
| Q1-2025 | $2.84B | $1.94B | $-1.02B | -35.81% | $-3.98 | $-687M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $562M ▼ | $25.14B ▼ | $10.99B ▼ | $14.12B ▼ |
| Q4-2025 | $590M ▼ | $25.54B ▼ | $11.35B ▼ | $14.15B ▼ |
| Q3-2025 | $621M ▼ | $25.77B ▼ | $11.49B ▼ | $14.24B ▼ |
| Q2-2025 | $816M ▲ | $26.12B ▼ | $11.69B ▼ | $14.4B ▲ |
| Q1-2025 | $613M | $28.27B | $15.05B | $13.18B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $170M ▲ | $257M ▼ | $23M ▲ | $-301M ▼ | $-28M ▲ | $92M ▼ |
| Q4-2025 | $18M ▼ | $318M ▲ | $-157M ▼ | $-200M ▲ | $-31M ▲ | $132M ▲ |
| Q3-2025 | $40M ▼ | $164M ▼ | $-115M ▼ | $-237M ▲ | $-195M ▼ | $30M ▼ |
| Q2-2025 | $612M ▲ | $241M ▲ | $2.7B ▲ | $-2.82B ▼ | $203M ▲ | $146M ▲ |
| Q1-2025 | $-1.02B | $127M | $-157M | $169M | $144M | $-52M |
Revenue by Products
| Product | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Food Ingredients | $850.00M ▲ | $830.00M ▼ | $800.00M ▼ | $840.00M ▲ |
Health Biosciences | $580.00M ▲ | $580.00M ▲ | $590.00M ▲ | $590.00M ▲ |
Scent | $600.00M ▲ | $650.00M ▲ | $610.00M ▼ | $650.00M ▲ |
Taste | $630.00M ▲ | $640.00M ▲ | $590.00M ▼ | $660.00M ▲ |
Pharma Solutions | $100.00M ▲ | $370.00M ▲ | $0 ▼ | $0 ▲ |
Revenue by Geography
| Region | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Asia | $650.00M ▲ | $620.00M ▼ | $610.00M ▼ | $660.00M ▲ |
EMEA | $950.00M ▲ | $930.00M ▼ | $890.00M ▼ | $950.00M ▲ |
Latin America | $360.00M ▲ | $360.00M ▲ | $340.00M ▼ | $350.00M ▲ |
North America | $800.00M ▲ | $780.00M ▼ | $740.00M ▼ | $790.00M ▲ |
Q1 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at International Flavors & Fragrances Inc.'s financial evolution and strategic trajectory over the past five years.
IFF combines a leading global position in flavors and fragrances with deep technical expertise, strong gross margins, and a wide, diversified product portfolio. Its long-standing, embedded relationships with large consumer-goods customers and its extensive R&D capabilities create real barriers to entry. The company has shown that it can generate substantial operating cash flow in good years, and its asset base—tangible and intangible—provides a strong platform for innovation and product development. Continued investment in sustainability, AI, and health-focused ingredients aligns the business with important long-term consumer and regulatory trends.
At the same time, IFF faces notable financial and operational risks. Revenue growth has stalled and then declined, and profitability has been highly volatile, with multiple years of sizable losses. Acquisitions have left the balance sheet more leveraged, goodwill and intangibles have been partially written down, retained earnings are negative, and liquidity metrics have weakened. Free cash flow is inconsistent, just as the company is trying to invest, deleverage, and maintain dividends. Competitive and customer pressures, integration challenges, and execution risks around portfolio reshaping all add further uncertainty.
Overall, IFF appears to be in a transition phase: strategically well positioned in an attractive industry and rich in innovation capabilities, but working through the financial consequences of past expansion and a tougher operating environment. The path forward likely hinges on stabilizing the top line, extracting more consistent efficiency gains, reducing leverage, and converting its strong R&D pipeline into steadier growth and more durable margins. This turnaround and optimization process may take time and is not guaranteed, but if successfully executed, it could eventually bring the financial profile more in line with the strength of the company’s competitive position.
About International Flavors & Fragrances Inc.
https://www.iff.comInternational Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $2.74B ▲ | $739M ▼ | $169M ▲ | 6.17% ▲ | $0.66 ▲ | $499M ▲ |
| Q4-2025 | $2.59B ▼ | $777M ▲ | $31M ▼ | 1.2% ▼ | $0.07 ▼ | $308M ▼ |
| Q3-2025 | $2.69B ▼ | $757M ▼ | $40M ▼ | 1.48% ▼ | $0.16 ▼ | $351M ▼ |
| Q2-2025 | $2.76B ▼ | $832M ▼ | $612M ▲ | 22.14% ▲ | $2.39 ▲ | $837M ▲ |
| Q1-2025 | $2.84B | $1.94B | $-1.02B | -35.81% | $-3.98 | $-687M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $562M ▼ | $25.14B ▼ | $10.99B ▼ | $14.12B ▼ |
| Q4-2025 | $590M ▼ | $25.54B ▼ | $11.35B ▼ | $14.15B ▼ |
| Q3-2025 | $621M ▼ | $25.77B ▼ | $11.49B ▼ | $14.24B ▼ |
| Q2-2025 | $816M ▲ | $26.12B ▼ | $11.69B ▼ | $14.4B ▲ |
| Q1-2025 | $613M | $28.27B | $15.05B | $13.18B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $170M ▲ | $257M ▼ | $23M ▲ | $-301M ▼ | $-28M ▲ | $92M ▼ |
| Q4-2025 | $18M ▼ | $318M ▲ | $-157M ▼ | $-200M ▲ | $-31M ▲ | $132M ▲ |
| Q3-2025 | $40M ▼ | $164M ▼ | $-115M ▼ | $-237M ▲ | $-195M ▼ | $30M ▼ |
| Q2-2025 | $612M ▲ | $241M ▲ | $2.7B ▲ | $-2.82B ▼ | $203M ▲ | $146M ▲ |
| Q1-2025 | $-1.02B | $127M | $-157M | $169M | $144M | $-52M |
Revenue by Products
| Product | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Food Ingredients | $850.00M ▲ | $830.00M ▼ | $800.00M ▼ | $840.00M ▲ |
Health Biosciences | $580.00M ▲ | $580.00M ▲ | $590.00M ▲ | $590.00M ▲ |
Scent | $600.00M ▲ | $650.00M ▲ | $610.00M ▼ | $650.00M ▲ |
Taste | $630.00M ▲ | $640.00M ▲ | $590.00M ▼ | $660.00M ▲ |
Pharma Solutions | $100.00M ▲ | $370.00M ▲ | $0 ▼ | $0 ▲ |
Revenue by Geography
| Region | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Asia | $650.00M ▲ | $620.00M ▼ | $610.00M ▼ | $660.00M ▲ |
EMEA | $950.00M ▲ | $930.00M ▼ | $890.00M ▼ | $950.00M ▲ |
Latin America | $360.00M ▲ | $360.00M ▲ | $340.00M ▼ | $350.00M ▲ |
North America | $800.00M ▲ | $780.00M ▼ | $740.00M ▼ | $790.00M ▲ |
Q1 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at International Flavors & Fragrances Inc.'s financial evolution and strategic trajectory over the past five years.
IFF combines a leading global position in flavors and fragrances with deep technical expertise, strong gross margins, and a wide, diversified product portfolio. Its long-standing, embedded relationships with large consumer-goods customers and its extensive R&D capabilities create real barriers to entry. The company has shown that it can generate substantial operating cash flow in good years, and its asset base—tangible and intangible—provides a strong platform for innovation and product development. Continued investment in sustainability, AI, and health-focused ingredients aligns the business with important long-term consumer and regulatory trends.
At the same time, IFF faces notable financial and operational risks. Revenue growth has stalled and then declined, and profitability has been highly volatile, with multiple years of sizable losses. Acquisitions have left the balance sheet more leveraged, goodwill and intangibles have been partially written down, retained earnings are negative, and liquidity metrics have weakened. Free cash flow is inconsistent, just as the company is trying to invest, deleverage, and maintain dividends. Competitive and customer pressures, integration challenges, and execution risks around portfolio reshaping all add further uncertainty.
Overall, IFF appears to be in a transition phase: strategically well positioned in an attractive industry and rich in innovation capabilities, but working through the financial consequences of past expansion and a tougher operating environment. The path forward likely hinges on stabilizing the top line, extracting more consistent efficiency gains, reducing leverage, and converting its strong R&D pipeline into steadier growth and more durable margins. This turnaround and optimization process may take time and is not guaranteed, but if successfully executed, it could eventually bring the financial profile more in line with the strength of the company’s competitive position.

CEO
Jon Erik Fyrwald
Compensation Summary
(Year 2025)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 1994-01-20 | Forward | 3:1 |
| 1974-12-17 | Forward | 51:50 |
ETFs Holding This Stock
Summary
Showing Top 3 of 684
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Barclays
Overweight
Citigroup
Buy
Oppenheimer
Outperform
JP Morgan
Overweight
UBS
Neutral
Mizuho
Outperform
Grade Summary
Showing Top 6 of 12
Price Target
Institutional Ownership
DODGE & COX
Shares:36.97M
Value:$2.81B
VANGUARD GROUP INC
Shares:31.13M
Value:$2.37B
WINDER INVESTMENT PTE LTD
Shares:25.36M
Value:$1.93B
Summary
Showing Top 3 of 1,132

